ARDS Flashcards
Diagnostic criteria for Acute Respiratory Distress Syndrome. (Harrison’s 19th edition, pp 1736)
PaO2/FiO2 (PF ratio) < or = 300mmHg
Acute onset
Bilateral alveolar or interstitial infiltrates
PCWP < or = 18 mmHg or no clinical evidence of increased left atrial pressure
Mild ARDS. (Harrison’s 19th edition, pp 1736)
PF ratio 201-300mmHg
Moderate ARDS. (Harrison’s 19th edition, pp 1736)
PF ratio 101-200mmHg
Severe ARDS. (Harrison’s 19th edition, pp 1736)
PF ratio < or = 100mmHg
Direct lung injury causes of ARDS. (Harrison’s 19th edition, pp 1736)
Pneumonia Aspiration of gastric contents Pulmonary contusion Near-drowning Toxic inhalation injury
Indirect lung injury causes of ARDS. (Harrison’s 19th edition, pp 1736)
Sepsis
Severe trauma (multiple bone fractures, flail chests, head trauma and burns)
Multiple transfusion
Drug overdose
Pancreatitis
Post cardiopulmonary bypass
(Shirley “Superb Practitioner” Panganiban, MD)
Phases of ARDS. (Harrison’s 19th edition, pp 1736-1738)
Exudative
Proliferative
Fibrotic
Recommended tidal volume for patients with ARDS who are on Mechanical ventilation. (Harrison’s 19th edition, pp 1738)
Low tidal volume (6mL/kg of predicted body weight)
Level A recommendations for ARDS therapy. (Harrison’s 19th edition, pp 1739)
Low tidal volume
Early neuromuscular blockade
Most important risk factor for ARDS mortality. (Harrison’s 19th edition, pp 1739)
Advanced age ( > 75 yo)
ARDS is a clinical syndrome of the following. (Harrison’s 19th edition, pp 1736)
Severe dyspnea
Hypoxemia
Diffuse pulmonary infiltrates leading to respiratory failure
Goals and limitations in the initial management if ARDS. (Harrison’s 19th edition, pp 1738)
Tidal volume < 6 ml/kg of ideal body weight Plateaue pressure < or = 30 RR < or = 35 FIO2 < or = 0.6 PEEP < 10 cmH2O SPO2 88-95% pH >/= 7.3 Diurese to maintain MAP >/= 65mmHg Avoid hypoperfusion
Phase of ARDS characterized by organization of alveolar exudates, shift from neutrophil to lymphocyte- predominant pulmonary infiltrate, and initiation of lung repair? (Harrison’s 19th edition, pp 1738)
Proliferative phase
Differential diagnosis of ARDS. (Harrison’s 19th edition, pp 1737)
Cardiogenic pulmonary edema
Diffuse pneumonia
Alveolar hemorrhage
Phase of ARDS characterized by sloughing of both the bronchial and alveolar epithelial cells, with the formation of protein-rich hyaline membranes on the denuded basement membrane. (Harrison’s 19th edition, pp 1737)
Exudative phase
Phase of ARDS characterized by conversion of alveolar edema and inflammatory exudates to extensive alveolar-duct and interstitial fibrosis. (Harrison’s 19th edition, pp 1738)
Fibrotic phase
Associated with increased mortality risk in ARDS. (Harrison’s 19th edition, pp 1738)
Lung biopsy evidence for pulmonary fibrosis
Condensed plasma proteins aggregate in the air spaces with cellular debris and dysfunctional pulmonary surfactant seen in exudative phase. (Harrison’s 19th edition, pp 1736)
Hyaline membrane whorls
Two processes required for ventilator-induced lung injury. (Harrison’s 19th edition, pp 1738)
Repeated alveolar overdistention
Recurrent alveolar collapse
Optimal PEEP. (Harrison’s 19th edition, pp 1738)
12-15mmHg
Predicts increased mortality risk from ARDS. (Harrison’s 19th edition, pp 1740)
Elevation of pulmonary dead space > 0.60
Severe arterial hypoxemia PF ratio < 100mHg
Initial oxygenation goals and limits in ARDS. (Harrison’s 19th edition, pp 1739)
FiO2 < or = 0.6
PEEP < or = 10cmH2O
SpO2 88-95%
Initial Volume/pressure-limited ventilation goals and limits in ARDS. (Harrison’s 19th edition, pp 1739)
Tidal volume < or = 6 ml/kg PBW
Plateau pressure < or = 30cmH2O
RR < or = 35 bpm
The only Class B recommendation of ARDS therapy. (Harrison’s 19th edition, pp 1739)
Minimized left atrial filling pressures
Trauma patients with an Acute Physiology and Chronic Health Evaluation (APACHE) II score __ have a 2.5 fold increased risk of developing ARDS. (Harrison’s 19th edition, pp 1736)
> /= 16
Trauma patients with an Acute Physiology and Chronic Health Evaluation (APACHE) II score __ have a 3 fold increased risk of developing ARDS. (Harrison’s 19th edition, pp 1736)
> 20
Patients usually recover maximal lung function. (Harrison’s 19th edition, pp 1740)
Within 6 months